688621 fundamentals
An in-depth look to BEIJING SUN-NOVOPHARMACEUTICALRESEARCHCO., LTD. operating, investing, and financing activities
688621 free cash flow for Q1 24 is -12.48 M CNY. For 2023, 688621 free cash flow was 21.19 M CNY and operating cash flow was 94.15 M CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM